CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advances

Patent ExpiryNegative
AI Analysis

Summary

Arbutus and Sanofi have escalated their mRNA patent disputes, while InnoCare advances its TYK2 inhibitor candidate.

Importance:4/10
Sentiment:
-0.50
patent disputemRNAlitigationTYK2 inhibitor
Related Companies

Read the original article

Published by yahoo_finance on July 17, 2026 10:07 AM

Read Original